Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penson

Showing results (311-320 of 1,177) with videos related to

Pageof 118
Sort By:
Current Atherosclerosis Reports|September 18, 2020
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with DyslipidaemiaPeter E Penson, Maciej Banach
Atherosclerosis|December 19, 2020
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomesPeter E Penson, Maciej Banach
Current Urology Reports|May 21, 2003
Quality of life after treatment for prostate cancerDavid F Penson, Mark S Litwin
The Journal of Urology|December 14, 2011
Re: Retropubic versus transobturator midurethral slings for stress incontinenceAlan J Wein, David F Penson
The Oncologist|September 7, 1999
Progress in gynecologic oncologyR T Penson, M V Seiden
The Urologic Clinics of North America|April 15, 2014
The politics of prostate cancer screeningSamuel D Kaffenberger, David F Penson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Reply to I.E. HainesDavid F Penson, Matthew J Resnick
Journal of Oncology Practice|January 9, 2014
The more, the merrier: including a medical oncologist in treatment planning for localized prostate cancerAlicia K Morgans, David F Penson
Trends in Cardiovascular Medicine|September 24, 2021
Editorial commentary: Bacterial lipopolysaccharide-Stoking the fire of residual risk?Peter E Penson, Neil C Henney
Prostate Cancer and Prostatic Diseases|December 24, 2002
Health-related quality of life in men with prostate cancerM S Litwin, D F Penson
Pageof 118

Showing results (311-320 of 1,177) with videos related to

Sort By:
Pageof 118
Current Atherosclerosis Reports|September 18, 2020
The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with DyslipidaemiaPeter E Penson, Maciej Banach
Atherosclerosis|December 19, 2020
Natural compounds as anti-atherogenic agents: Clinical evidence for improved cardiovascular outcomesPeter E Penson, Maciej Banach
Current Urology Reports|May 21, 2003
Quality of life after treatment for prostate cancerDavid F Penson, Mark S Litwin
The Journal of Urology|December 14, 2011
Re: Retropubic versus transobturator midurethral slings for stress incontinenceAlan J Wein, David F Penson
The Oncologist|September 7, 1999
Progress in gynecologic oncologyR T Penson, M V Seiden
The Urologic Clinics of North America|April 15, 2014
The politics of prostate cancer screeningSamuel D Kaffenberger, David F Penson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Reply to I.E. HainesDavid F Penson, Matthew J Resnick
Journal of Oncology Practice|January 9, 2014
The more, the merrier: including a medical oncologist in treatment planning for localized prostate cancerAlicia K Morgans, David F Penson
Trends in Cardiovascular Medicine|September 24, 2021
Editorial commentary: Bacterial lipopolysaccharide-Stoking the fire of residual risk?Peter E Penson, Neil C Henney
Prostate Cancer and Prostatic Diseases|December 24, 2002
Health-related quality of life in men with prostate cancerM S Litwin, D F Penson
Pageof 118